Interstitial Lung Disease Update: Should We Treat Asymptomatic ILD? Is There a Need for Salvage Therapies with Rituximab, Tocilizumab, and IVIg? What Is the Best Treatment Approach?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Interstitial Lung Disease Update: Should We Treat Asymptomatic ILD? Is There a Need for Salvage Therapies with Rituximab, Tocilizumab, and IVIg? What Is the Best Treatment Approach?

By Cleveland Clinic Rheumatology FEATURING Joseph Parambil

125 views

September 18, 2020

0 Comments

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Feat. A. Brown

22:27

USSONAR

USSONAR Case Series: A Patient With Shoulder and Hip Pain

Feat. K. Shah

07:57

Temple Lung Center

Clinical Trials for Pulmonary Fibrotic Diseases

Feat. G. Criner

05:58

Cleveland Clinic Rheumatology

Ever-Evolving Lupus Case & Cytopenias in SLE

Feat. E. Littlejohn

15:45

Daniel Arkfeld

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

24:23

NYU Langone

How RA Associated HLA-DR Molecules Contribute to the Development of …

Feat. J. Roudier

45:17

ARTHROS

Update in the Understanding and Management of Lupus

Feat. M. Petri

52:53

University of Colorado Department of Medicine

Interstitial Lung Disease in Rheumatic Diseases

Feat. M. Griffith

17:39

Saakshi Khattri

Dermatologic Manifestations in Rheumatic Diseases

21:41

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

Feat. S. Metyas

21:34

CHEST 2022 Coverage

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

Feat. T. Kulkarni

14:09

Keck School of Medicine of USC

Vitamin D Deficiency

Feat. V. Gevorgyan

10:53

RheumNow

Diagnosing Neuropsychiatric Lupus

Feat. J. Cush

58:00

West Virginia State Rheumatology Society

2022 Updates on the Management of Lupus Nephritis

Feat. M. Petri

11:54

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Embedding Treat to Target Principle…

Feat. S. Dowell

23:59

RheumNow

Methotrexate Use: 50 Year Perspective

Feat. J. Kremer

15:08

Johns Hopkins Rheumatology

Diagnosis and Treatment of Idiopathic Inflammatory Myositis: What Ar…

Feat. C. Mecoli

34:08

Keck School of Medicine of USC

Medical Marijuana in Rheumatology: Fact or Fiction?

Feat. A. Wells

25:25

Keck School of Medicine of USC

Update on the New ANA Classification System

Feat. E. Taylor-Albert

19:54

Michelle Petri

Login

Login

Join VuMedi

Interstitial Lung Disease Update: Should We Treat Asymptomatic ILD? Is There a Need for Salvage Therapies with Rituximab, Tocilizumab, and IVIg? What Is the Best Treatment Approach?

Related Content